AbbVie Confronts 1st Bellwether In Androgel MDL

Law360, New York (June 5, 2017, 8:39 PM EDT) -- AbbVie Inc. is facing its first test in multidistrict litigation accusing the pharmaceutical company and several others of overselling testosterone replacement drugs and not warning of potentially deadly side effects, with a Tennessee man alleging before an Illinois federal jury Monday that AbbVie's Androgel caused his heart attack.

Jeffrey Konrad and his wife, Jana Konrad, have filed one of the over 4,200 cases accusing AbbVie of promoting Androgel beyond its U.S. Food and Drug Administration authorized use while misleading doctors about the dangerous side effects of the drug.

Jeffrey Konrad had a heart attack in 2010, which he links to prescription...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!